Posaconazole in the Prevention of COVID-19-associated Mucormycosis: A Concerning Contributor to the Rise in Antifungal Resistance

How to cite this article: Kayarat B, Khanna P. Posaconazole in the Prevention of COVID-19-associated Mucormycosis: A Concerning Contributor to the Rise in Antifungal Resistance. Indian J Crit Care Med 2021;25(10):1209–1210.

Detalles Bibliográficos
Autores principales: Kayarat, Bhavana, Khanna, Puneet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Jaypee Brothers Medical Publishers 2021
Materias:
Letter to Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645813/
https://www.ncbi.nlm.nih.gov/pubmed/34916761
http://dx.doi.org/10.5005/jp-journals-10071-23981
_version_ 1784610387493126144
author Kayarat, Bhavana
Khanna, Puneet
author_facet Kayarat, Bhavana
Khanna, Puneet
author_sort Kayarat, Bhavana
collection PubMed
description How to cite this article: Kayarat B, Khanna P. Posaconazole in the Prevention of COVID-19-associated Mucormycosis: A Concerning Contributor to the Rise in Antifungal Resistance. Indian J Crit Care Med 2021;25(10):1209–1210.
format Online
Article
Text
id pubmed-8645813
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Jaypee Brothers Medical Publishers
record_format MEDLINE/PubMed
spelling pubmed-86458132021-12-15 Posaconazole in the Prevention of COVID-19-associated Mucormycosis: A Concerning Contributor to the Rise in Antifungal Resistance Kayarat, Bhavana Khanna, Puneet Indian J Crit Care Med Letter to Editor How to cite this article: Kayarat B, Khanna P. Posaconazole in the Prevention of COVID-19-associated Mucormycosis: A Concerning Contributor to the Rise in Antifungal Resistance. Indian J Crit Care Med 2021;25(10):1209–1210. Jaypee Brothers Medical Publishers 2021-10 /pmc/articles/PMC8645813/ /pubmed/34916761 http://dx.doi.org/10.5005/jp-journals-10071-23981 Text en Copyright © 2021; Jaypee Brothers Medical Publishers (P) Ltd. https://creativecommons.org/licenses/by-nc/4.0/© The Author(s). 2021 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted use, distribution, and non-commercial reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated.
spellingShingle Letter to Editor
Kayarat, Bhavana
Khanna, Puneet
Posaconazole in the Prevention of COVID-19-associated Mucormycosis: A Concerning Contributor to the Rise in Antifungal Resistance
title Posaconazole in the Prevention of COVID-19-associated Mucormycosis: A Concerning Contributor to the Rise in Antifungal Resistance
title_full Posaconazole in the Prevention of COVID-19-associated Mucormycosis: A Concerning Contributor to the Rise in Antifungal Resistance
title_fullStr Posaconazole in the Prevention of COVID-19-associated Mucormycosis: A Concerning Contributor to the Rise in Antifungal Resistance
title_full_unstemmed Posaconazole in the Prevention of COVID-19-associated Mucormycosis: A Concerning Contributor to the Rise in Antifungal Resistance
title_short Posaconazole in the Prevention of COVID-19-associated Mucormycosis: A Concerning Contributor to the Rise in Antifungal Resistance
title_sort posaconazole in the prevention of covid-19-associated mucormycosis: a concerning contributor to the rise in antifungal resistance
topic Letter to Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645813/
https://www.ncbi.nlm.nih.gov/pubmed/34916761
http://dx.doi.org/10.5005/jp-journals-10071-23981
work_keys_str_mv AT kayaratbhavana posaconazoleinthepreventionofcovid19associatedmucormycosisaconcerningcontributortotheriseinantifungalresistance
AT khannapuneet posaconazoleinthepreventionofcovid19associatedmucormycosisaconcerningcontributortotheriseinantifungalresistance

Ejemplares similares